Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive 

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-58724

Lee, B; Clarke, D; Al Ahmad, A; Kahle, M; Parham, C; Auckland, L; Shaw, C; Fidanboylu, M; Orr, A W; Ogunshola, O; Fertala, A; Thomas, S A; Bix, G J (2011). Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents. Journal of Clinical Investigation, 121(8):3005-3023.

[img]
Preview
Published Version
PDF
7MB

Abstract

Stroke is the leading cause of long-term disability and the third leading cause of death in the United States. While most research thus far has focused on acute stroke treatment and neuroprotection, the exploitation of endogenous brain self-repair mechanisms may also yield therapeutic strategies. Here, we describe a distinct type of stroke treatment, the naturally occurring extracellular matrix fragment of perlecan, domain V, which we found had neuroprotective properties and enhanced post-stroke angiogenesis, a key component of brain repair, in rodent models of stroke. In both rat and mouse models, Western blot analysis revealed elevated levels of perlecan domain V. When systemically administered 24 hours after stroke, domain V was well tolerated, reached infarct and peri-infarct brain vasculature, and restored stroke-affected motor function to baseline pre-stroke levels in these multiple stroke models in both mice and rats. Post-stroke domain V administration increased VEGF levels via a mechanism involving brain endothelial cell α5β1 integrin, and the subsequent neuroprotective and angiogenic actions of domain V were in turn mediated via VEGFR. These results suggest that perlecan domain V represents a promising approach for stroke treatment.

Item Type:Journal Article, refereed, original work
Communities & Collections:05 Vetsuisse Faculty > Institute of Veterinary Physiology
DDC:570 Life sciences; biology
Language:English
Date:2011
Deposited On:12 Mar 2012 11:51
Last Modified:26 Dec 2013 04:10
Publisher:American Society for Clinical Investigation
ISSN:0021-9738
Publisher DOI:10.1172/JCI46358
PubMed ID:21747167
Citations:Web of Science®. Times Cited: 23
Google Scholar™
Scopus®. Citation Count: 30

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page